Broadcom (AVGO) reports Q1 earnings today with strong AI networking estimates, but caution grows after Nvidia’s post-earnings decline. What to watch.
Browsing: News
Mobix Labs (MOBX) stock exploded 257% after securing a production order for filtering components used in the U.S. Navy’s Tomahawk cruise missile program.
Strategy (MSTR) stock climbs 7% pre-market as STRC preferred stock trading volume of $198.7M suggests 1,000 BTC purchase—the largest since July 2025 launch.
Bitcoin jumped 5% Wednesday, boosting crypto stocks like Strategy and Coinbase. Moderna settled a $950M patent case. Ross Stores exceeded earnings expectations.
Billionaire Leo KoGuan bought 1M Nvidia (NVDA) shares, calling AI ‘not a bubble.’ UBS maintains Buy rating with $245 target as backlog extends to 2027.
Airbus (AIR) wins €1.1M EDA contract through Survey Copter for 48-month M2UAS project to expand tactical drone capabilities across military missions.
Gold prices dropped 4.5% before rebounding 2% as US-Iran tensions, a stronger dollar, and rising oil prices create volatility in precious metals markets.
Adidas (ADS) stock dropped 8% after the sportswear giant projected 2026 operating profit of €2.3B, missing consensus amid tariff and currency pressures.
Nuburu (BURU) stock crashes 40% after $12M offering and reverse split. Company partners with Maddox Defense while revenue drops 98% to just $10,000.
Novo Nordisk (NVO) stock jumped 3% after the FDA warned 30 telehealth companies about false advertising of compounded GLP-1 drugs like semaglutide.
ServiceNow (NOW) stock jumped 3.7% to $113.44 on Tuesday after unveiling AI products and partnering with NTT DOCOMO and StarHub on autonomous telecom solutions.
Wix (WIX) Q4 2025 results show EPS beat at $1.81 vs $1.42 estimate, but revenue of $524.3M misses targets. Base44 hits $100M ARR, $250M placement announced.
Micron (MU) stock fell 8% Tuesday on geopolitical risks. Wall Street maintains Strong Buy consensus with targets up to $550 ahead of March 18 earnings call.
CrowdStrike (CRWD) exceeds Q4 estimates with $1.31B revenue and $1.12 EPS. ARR climbs to $5.25B as the cybersecurity firm guides Q1 above consensus.
Moderna (MRNA) stock soared 8.7% after settling patent litigation with Arbutus and Genevant for $950M in pharma’s largest patent settlement ever.